Latest News about ABBV
Recent news which mentions ABBV
From Motley Fool
3 Dividend Stocks That Are Screaming Buys in November
Today 7:20 EST
From Motley Fool
This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
November 22, 2024
From Benzinga
Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
November 18, 2024
Tickers
ABBV
From Motley Fool
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
November 17, 2024
From Benzinga
AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'
November 15, 2024
From Benzinga
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
November 15, 2024
Tickers
ABBV
From Motley Fool
Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
November 14, 2024
From Benzinga
2 Dividend Stocks to Buy Hand Over Fist in November
November 14, 2024
From Motley Fool
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 11, 2024
From Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
November 11, 2024
From Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
November 11, 2024
From Benzinga
AbbVie Shares Plunge as Experimental Schizophrenia Drug Flops in Trials
November 11, 2024
From Wall Street Pit
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
November 11, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|